2TAZZYMAN S, LEWIS C E, MURDOCH C. Neutrophils: key mediators of tumour angiogenesis[J]. International Jour- nal of Experimental Pathology, 2009,90(3):222-231.
3SZKANDERA J, STOTZ M, EISNER F, et al. External vali- dation of the derived neutrophil to lymphocyte ratio as a prog nostic marker on a large cohort of pancreatic cancer patients [J]. PLoS One, 2013,8(11): e782251-e782255.
4SHIMADA H, TAKIGUCHI N, KAINUMA Osamu, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer[J]. Gastric Cancer: Of- ficial Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2010, 13 (3):170-176.
5GARCEA G, LADWA N, NEAL C P, et al. Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with re duced disease-free survival following curative resection of pan- creatic adenoearcinoma[J]. World Journal of Surgery, 2011,35 (4) :868-872.
6AZAB B, SHAH N, RADBEL J, et al. Pretreatment neutro- phil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients [J]. Medical Oneology (Northwood, London, England), 2013,30(1) :432-436.
7BROOKMAN-MAY S D, MAY M, SHARIAT S F, et al. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre data- base (Corona/Saturn-Project)[J]. BJU Int, 2013(112): 909- 916.
9OHNO Y, NAKASHIMA JUN, OHORI M, et al. Pretreat- ment neutrophil-to-lymphocyte ratio as an independent predic- tor of recurrence in patients with nonmetastatic renal cell carci- noma[J]. The Journal of Urology, 2010,184(3) : 873-878.
10DE MARTINO M, PANTUCK A J, HOFBAUER S, et al. Prognostic impact of preoperative neutrophil-to-lymphocyte ra- tio in localized nonclear cell renal cell carcinoma[J]. The Jour- nal of Urology, 2013,190(6) : 1999-2004.
4RASPOLLINI M R, ASIRELLI G, TADDEI G L. The role of angiogenesis and COX-2 expression in the evolution of vulvar lichen sclerosus to squamous cell carcinoma of the vulva[J]. Gynecologic Oncology, 2007,106(3) : 567-571.
5HIDA T, KOZAKI K, MURAMATSU H, et al. Cyclooxy- genase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines[J]. Clin Cancer Res, 2000,6(5):2006-2011.
6MORAN E M. Epidemiological and clinical aspects of nonste roidal anti-inflammatory drugs and cancer risks[J]. Journal of Environmental Pathology, Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicolo- gy and Cancer, 2002,21 (2) : 193-201.
